Ittner Lars M, Ke Yazi D, Götz Jürgen
Alzheimer's and Parkinson's Disease Laboratory, Brain and Mind Research Institute, University of Sydney, Sydney, Camperdown, New South Wales 2050, Australia.
J Biol Chem. 2009 Jul 31;284(31):20909-16. doi: 10.1074/jbc.M109.014472. Epub 2009 Jun 2.
In Alzheimer disease (AD) and frontotemporal dementia the microtubule-associated protein Tau becomes progressively hyperphosphorylated, eventually forming aggregates. However, how Tau dysfunction is associated with functional impairment is only partly understood, especially at early stages when Tau is mislocalized but has not yet formed aggregates. Impaired axonal transport has been proposed as a potential pathomechanism, based on cellular Tau models and Tau transgenic mice. We recently reported K369I mutant Tau transgenic K3 mice with axonal transport defects that suggested a cargo-selective impairment of kinesin-driven anterograde transport by Tau. Here, we show that kinesin motor complex formation is disturbed in the K3 mice. We show that under pathological conditions hyperphosphorylated Tau interacts with c-Jun N-terminal kinase- interacting protein 1 (JIP1), which is associated with the kinesin motor protein complex. As a result, transport of JIP1 into the axon is impaired, causing JIP1 to accumulate in the cell body. Because we found trapping of JIP1 and a pathological Tau/JIP1 interaction also in AD brain, this may have pathomechanistic implications in diseases with a Tau pathology. This is supported by JIP1 sequestration in the cell body of Tau-transfected primary neuronal cultures. The pathological Tau/JIP1 interaction requires phosphorylation of Tau, and Tau competes with the physiological binding of JIP1 to kinesin light chain. Because JIP1 is involved in regulating cargo binding to kinesin motors, our findings may, at least in part, explain how hyperphosphorylated Tau mediates impaired axonal transport in AD and frontotemporal dementia.
在阿尔茨海默病(AD)和额颞叶痴呆中,微管相关蛋白Tau逐渐过度磷酸化,最终形成聚集体。然而,Tau功能障碍与功能损害之间的关联仅得到部分理解,尤其是在Tau定位错误但尚未形成聚集体的早期阶段。基于细胞Tau模型和Tau转基因小鼠,轴突运输受损被认为是一种潜在的病理机制。我们最近报道了K369I突变型Tau转基因K3小鼠存在轴突运输缺陷,这表明Tau对驱动蛋白驱动的顺行运输具有货物选择性损害。在此,我们表明K3小鼠中驱动蛋白运动复合体的形成受到干扰。我们发现,在病理条件下,过度磷酸化的Tau与c-Jun氨基末端激酶相互作用蛋白1(JIP1)相互作用,而JIP1与驱动蛋白运动蛋白复合体相关。结果,JIP1向轴突的运输受损,导致JIP1在细胞体中积累。因为我们在AD大脑中也发现了JIP1的滞留以及病理性Tau/JIP1相互作用,这可能对具有Tau病理学的疾病具有病理机制意义。Tau转染的原代神经元培养物的细胞体中JIP1的隔离支持了这一点。病理性Tau/JIP1相互作用需要Tau的磷酸化,并且Tau与JIP1与驱动蛋白轻链的生理性结合竞争。由于JIP1参与调节货物与驱动蛋白马达的结合,我们的发现可能至少部分解释了过度磷酸化的Tau如何介导AD和额颞叶痴呆中的轴突运输受损。